A Phase 1 Study of S-1117
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Healthy Volunteer
In brief
This is the first-in-human study of S-1117 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.
Key facts
- Study ID
- NCT06828393
- Run by
- Seismic Therapeutic AU Pty Ltd
- People needed
- 96
- Starts
- 2025-03-01
- Expected to finish
- 2026-03-01
- Last updated by the study team
- 2025-03-12
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- CMAX Clinical Research — Adelaide, South Australia, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.